The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
- (-) Weight loss products (4)
- (-) In Vitro Diagnostic medical devices (IVDs) (2)
- Advertising (222)
- Regulatory compliance (96)
- Prescription medicines (64)
- COVID-19 (50)
- Therapeutic goods regulation (43)
- Medicine safety (27)
- Vaping hub (26)
- Compliance and enforcement hub (22)
- Medicinal cannabis hub (17)
- Import and export (15)
- COVID-19 vaccines (13)
- Medical devices safety (12)
- Scheduling (national classification system) (12)
- Manufacturing (9)
- Complementary medicines (8)
- Listed medicines (8)
- Australian Register of Therapeutic Goods (ARTG) (7)
- Safety (7)
- Legislation (6)
- Non-prescription medicines (6)
- Over the counter (OTC) medicines (5)
- Alert/Advisory (4)
- Labelling and packaging (4)
- Shortages (4)
- Cosmetics (2)
- Prescription opioids hub (2)
- Advisory bodies and committees (1)
- Assessed listed medicines (1)
- Fees and payments (1)
- Sunscreens (1)
- Travelling with health products (1)
- Unique Device Identification (UDI) hub (1)
Filters applied:Clear all
Search
6 result(s) found, displaying 1 to 6
-
Media releasesWe have accepted a court-enforceable undertaking from Your Solution Compounding Pharmacy Pty Ltd, regarding advertising of prescription-only compounded medicines for weight-loss.
-
Media releasesThe TGA reminds businesses and media outlets that it is unlawful to publicly advertise prescription-only medicines, including prescription-only weight loss medicines.
-
2San Pty Ltd enters into enforceable undertaking after unlawful import and supply of medical devices
Media releasesThe company imported medical devices not included in the Australian Register of Therapeutic Goods. They supplied these devices to a national retailer, who then sold them to the public. -
Media releasesAmendments to the Therapeutic Goods Regulations 1990 (Schedule 5, item 6) have been made resulting in compounded GLP-1 RA products no longer being able to be compounded by pharmacists and supplied to patients.
-
Media releasesThe TGA is aware of several scams targeting consumers seeking semaglutide (Ozempic). Consumers are strongly advised not to use products unless they have come from a trusted source.
-
Media releasesThe TGA has approved the first two nasal combination self-tests (for use at home) that detect both COVID-19 and influenza viral infections in humans.